{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:45:44Z","timestamp":1793573144758,"version":"4.5.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81871187"],"award-info":[{"award-number":["No. 81871187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81460239"],"award-info":[{"award-number":["No. 81460239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ningxia Natural Science Foundation Project","award":["No. NZ17195"],"award-info":[{"award-number":["No. NZ17195"]}]},{"name":"Qingdao Outstanding Health Professional Development Fund"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hypertension in Pregnancy"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/10641955.2023.2209637","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T05:21:12Z","timestamp":1689139272000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis"],"prefix":"10.1080","volume":"42","author":[{"given":"Minghui","family":"Ou","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, The People\u2019s Hospital of Qingdao Chengyang District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Qingdao Municipal Hospital, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"e_1_3_6_2_1","volume-title":"Hypertension in Pregnancy. StatPearls","author":"Luger RK","year":"2022","unstructured":"Luger RK, Kight BP. Hypertension in Pregnancy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC; 2022."},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.01.006"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68397-9"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2017.1308321"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13463"},{"issue":"3","key":"e_1_3_6_8_1","first-page":"141","article-title":"Nelsonpiercy C ea. 9 pregnancy and chronic hypertension: nifedipine vs labetalol as antihypertensive treatment (the panda study): anti-hypertensive medications","volume":"6","author":"Nelson-Piercy C LWM","year":"2016","unstructured":"Nelson-Piercy C LWM. Nelsonpiercy C ea. 9 pregnancy and chronic hypertension: nifedipine vs labetalol as antihypertensive treatment (the panda study): anti-hypertensive medications. Pregnancy Hypertens Int J Womens Cardiovasc Health. 2016;6(3):141\u2013.","journal-title":"Pregnancy Hypertens Int J Womens Cardiovasc Health"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.05.004"},{"key":"e_1_3_6_10_1","first-page":"e1","article-title":"Gestational hypertension and preeclampsia","volume":"133","author":"Committee A","year":"2019","unstructured":"Committee A. Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:e1\u201325.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2009.01003.x"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/039139880202501002"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2014.01.003"},{"key":"e_1_3_6_14_1","volume-title":"Children\u2019s H. National Institute for Health and Clinical Excellence: guidance. Hypertension in Pregnancy: the Management of Hypertensive Disorders During Pregnancy","author":"National Collaborating Centre for Ws","year":"2022","unstructured":"National Collaborating Centre for Ws. Children\u2019s H. National Institute for Health and Clinical Excellence: guidance. Hypertension in Pregnancy: the Management of Hypertensive Disorders During Pregnancy. London: RCOG Press Copyright \u00a9 2022, StatPearls Publishing LLC; 2022."},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001449.pub3"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12737"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7421.955"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7194.1332"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.10.111"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.01.022"},{"key":"e_1_3_6_21_1","first-page":"1673","article-title":"Oral nifedipine versus intravenous labetalol in hypertensive emergencies of pregnancy: a randomised trial","volume":"6","author":"Dhananjaya BS","year":"2015","unstructured":"Dhananjaya BS, Jamuna R. Oral nifedipine versus intravenous labetalol in hypertensive emergencies of pregnancy: a randomised trial. Res J Pharm Biol Chem Sci. 2015;6:1673\u20131681.","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2016.08.008"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.956093"},{"key":"e_1_3_6_24_1","unstructured":"Higgins JPT Thomas J Chandler J et al. Cochrane handbook for systematic reviews of interventions version 6.2. Cochrane; 2021 [updated 2021 Feb; Accessed 2023 Apr 10]. www.training.cochrane.org\/handbook"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019703"},{"issue":"3","key":"e_1_3_6_29_1","first-page":"10","article-title":"Practical considerations on detection of publication bias","volume":"20","author":"Palma Perez S","year":"2006","unstructured":"Palma Perez S, Delgado Rodriguez M. Practical considerations on detection of publication bias. Gac Sanit. 2006;20(Suppl 3):10\u201316.","journal-title":"Gac Sanit"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.5455\/2320-1770.ijrcog001912"},{"issue":"14","key":"e_1_3_6_31_1","first-page":"2346","article-title":"Comparative effects of magnesium sulfate plus nifedipine or labetalol for the treatment of pregnancy-induced hypertension [in Chinese]","volume":"27","author":"Fu ZM","year":"2016","unstructured":"Fu ZM, Wang AL, Pei XY. Comparative effects of magnesium sulfate plus nifedipine or labetalol for the treatment of pregnancy-induced hypertension [in Chinese]. Hainan Med J. 2016;27(14):2346\u20132348.","journal-title":"Hainan Med J"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.02.011"},{"issue":"6","key":"e_1_3_6_33_1","first-page":"1","article-title":"A comparative evaluation of intravenous labetalol versus oral nifedipine for control of severe pregnancy-induced hypertension with low-dose regimen","volume":"5","author":"Mukherjee S","year":"2015","unstructured":"Mukherjee S, Khan S, Jain U. A comparative evaluation of intravenous labetalol versus oral nifedipine for control of severe pregnancy-induced hypertension with low-dose regimen. Int JMed Sci Public Health. 2015;5(6):1.","journal-title":"Int JMed Sci Public Health"},{"issue":"22","key":"e_1_3_6_34_1","first-page":"91","article-title":"Clinical effect of nifedipine and labetalol in the treatment of severe pregnancy-induced hypertension [in Chinese]","volume":"8","author":"Pei YX","year":"2015","unstructured":"Pei YX, Zhang XY, Li JC, et al. Clinical effect of nifedipine and labetalol in the treatment of severe pregnancy-induced hypertension [in Chinese]. Chinese J Clinical Rational Drug Use. 2015;8(22):91\u201392.","journal-title":"Chinese J Clinical Rational Drug Use"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.03151.x"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1258\/om.2012.120010"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a9ea68"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12439"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70314-5"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2022.2056196"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000054218"},{"issue":"3","key":"e_1_3_6_42_1","first-page":"328","article-title":"A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy","volume":"70","author":"Mabie WC","year":"1987","unstructured":"Mabie WC, Gonzalez AR, Sibai BM, et al. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987;70(3 Pt 1):328\u2013333.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/105918"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002019"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.09.019"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13649"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10020325"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy340"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.10.780"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09972"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.09.019"},{"key":"e_1_3_6_52_1","unstructured":"World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011."}],"container-title":["Hypertension in Pregnancy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10641955.2023.2209637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T09:34:42Z","timestamp":1702460082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10641955.2023.2209637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/10641955.2023.2209637"],"URL":"https:\/\/doi.org\/10.1080\/10641955.2023.2209637","relation":{},"ISSN":["1064-1955","1525-6065"],"issn-type":[{"value":"1064-1955","type":"print"},{"value":"1525-6065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihip20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihip20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2209637"}}